# Briefing: realistic generative-AI uses in insurance claims

**Audience:** claims, risk, compliance and technology leaders  
**Bottom line:** Deploy generative AI first as a *copilot* for intake, retrieval, summarisation, triage and drafting. It is materially less suitable as an autonomous authority on coverage, medical necessity, fraud, denials or settlement amounts. Automate preparation; retain accountable human judgement for consequential outcomes. The examples below also include conventional AI/computer vision and workflow automation: controls should follow potential consumer impact, not the technology label.

## Where it can help now

| Claims activity | Realistic use | Primary benefit |
|---|---|---|
| First notice of loss (FNOL) and service | Conversational intake, transcription, multilingual answers, missing-information requests and status updates | Faster access and fewer manual handoffs |
| File and document work | Extract and summarise policy provisions, medical records, repair estimates, invoices, police reports, emails and notes; build a chronology | Less searching; more adjuster capacity |
| Adjuster copilot | Retrieve applicable procedures, suggest next questions/actions, draft routine correspondence and explain the evidence in a file | More consistent preparation and communication |
| Triage and routing | Recommend urgency, complexity, specialist assignment or escalation | Earlier attention to severe/complex claims |
| Fraud and recovery support | Surface inconsistencies and relationships across documents, images and prior claims; organise subrogation evidence and draft demand packages | Better investigation leads and recovery workflow |
| Damage assessment | Summarise photos/video/telematics and draft a preliminary repair-versus-replace assessment | Quicker estimates, with inspection exceptions |

These are consistent with applications identified by NAIC (including accident-image analysis, settlement-value estimation and fraud detection), EIOPA (claims intake, image recognition, repair decisions and chatbots), and live industry pilots such as Allianz’s claims copilot and Scottish Widows’ medical-file summarisation. The public evidence is mainly pilots, surveys and vendor/insurer announcements—not independent proof of improved claim accuracy or fairness. Sources: [NAIC AI topic](https://content.naic.org/insurance-topics/artificial-intelligence); [EIOPA Consumer Trends Report 2024](https://www.eiopa.europa.eu/document/download/4f3b2964-455d-497e-b69f-b5c5939d7aee_en?filename=Eurobarometer+CTR+2024+-+Report.pdf); [Allianz](https://www.allianz.com/en/mediacenter/news/articles/250205-smarter-claims-management-smoother-settlements.html); [Scottish Widows](https://www.scottishwidows.co.uk/about-us/media-centre/press-releases/ai-to-speed-up-protection-insurance.html).

## Benefits worth testing—not assuming

- Lower handling time and administrative cost through fewer searches, re-keying and handoffs.
- Potentially faster, more accessible first-line service, provided authentication, translation quality, accessibility, accuracy and prompt access to a human are tested.
- More consistent file preparation: prompts for missing evidence, relevant policy terms, deadlines and escalation.
- Better use of unstructured evidence, potentially improving investigator productivity and anomaly detection.

Set success measures around **outcomes**, not just speed: accuracy and completeness, payment and reserve accuracy, reopened claims, complaints/appeals, vulnerable-customer outcomes, fraud-referral quality, adjuster overrides and disparate error rates. Published benefits should be treated as hypotheses until measured in the carrier’s own portfolio.

## Failure modes that can harm claimants

1. **Hallucinated or omitted facts.** A fluent summary can invent a policy term, deadline, medical conclusion or repair cost—or omit an exclusion. A generated denial or reservation-of-rights letter can therefore be wrong while sounding authoritative.
2. **Automation bias and inconsistency.** Adjusters may rubber-stamp a recommendation; different prompts, model versions or languages may produce different treatment of similar claims.
3. **Bias and proxy discrimination.** Historical claims data, geography, language or other proxies can skew triage, investigation intensity, service quality or settlement recommendations. Excluding protected attributes does not remove this risk.
4. **Exceptional and vulnerable cases.** A chatbot or standard workflow may miss catastrophe complexity, distress, disability, language needs or novel coverage facts; fraud “signals” can become unsupported suspicion.
5. **Privacy and security loss.** Claims contain health, financial, identity, litigation and location data. Untrusted attachments can also attempt prompt injection or exfiltration.
6. **Synthetic evidence and adversarial manipulation.** Deepfake images, altered invoices or medical documents can mislead models and investigators.
7. **Weak accountability and evidence trail.** If prompts, retrieved sources, model version and human edits are not retained, the carrier may be unable to explain or reconstruct a delay, payment, referral or denial. Vendor model changes can silently alter outcomes.

The IAIS’s 2025 application paper groups supervisory concerns around proportionality, governance, robustness/security, transparency/explainability, fairness and redress. NAIC likewise expects insurers to manage AI risks and comply with existing claims and discrimination law; a vendor does not take away the insurer’s accountability. Sources: [IAIS](https://www.iais.org/2025/07/the-iais-publishes-application-paper-on-the-supervision-of-artificial-intelligence/); [NAIC Model Bulletin (PDF)](https://content.naic.org/sites/default/files/inline-files/2023-12-4%20Model%20Bulletin_Adopted_0.pdf).

## Minimum viable control set

**Risk-tier the use case.** Apply the lightest controls to internal search/transcription, stronger controls to triage/fraud/settlement recommendations, and the strongest controls to anything that can affect eligibility, payment, delay, denial, benefits or a vulnerable claimant. As an internal default, prohibit autonomous decisions that materially affect a claim unless legal, claims, compliance and risk owners document the authority, controls and escalation route; this is a prudent control standard, not a universal legal rule.

**Ground and constrain outputs.** Use an approved, access-controlled retrieval corpus (the actual policy, endorsements, claim file and jurisdictional procedures); display document identity, effective date and supporting passages; distinguish extracted fact from inference; and block answers when evidence is missing or contradictory. Use evidence-sufficiency, contradiction and exception flags rather than unvalidated confidence scores. Treat every claimant document as untrusted input; isolate tools and allow-list actions.

**Keep meaningful human authority.** For consequential use cases, a trained claims professional should see the underlying evidence, exercise genuine authority to reject/override the output, record an independent rationale and escalate unusual, high-severity, vulnerable or low-evidence cases. A nominal click-through approval is not meaningful review.

**Protect claimant interactions and communications.** Authenticate claimants and representatives before disclosing claim, medical, payment or policy information; prevent cross-claim leakage and separately control payment-instruction changes. Do not send coverage, reservation-of-rights, denial, limitation, settlement or deadline communications without verified policy/jurisdictional sources, controlled templates and appropriately authorised human review. Preserve the final wording sent.

**Handle medical and fraud use carefully.** For medical claims, restrict processing to an approved purpose and legal basis, segregate health data, validate extraction against the source record and require qualified review before a medical conclusion affects coverage, necessity, causation, reserve or payment. Treat AI fraud output as an investigative lead only: require corroborating evidence and never deny, delay or intensify investigation solely because of a model score or generated suspicion.

**Validate and monitor.** Before release and continuously thereafter, test factual accuracy, omissions, similar-claim consistency, rare/catastrophe cases, languages/accessibility, bias/disparate impact, prompt injection, deepfakes, drift and vendor updates. Define error taxonomies, denominators, sample sizes, uncertainty ranges, materiality thresholds and remediation owners; monitor by product, jurisdiction, language, severity and channel. Track errors, overrides, complaints, appeals, reopenings, payment/denial/delay/referral rates, outcome disparities and cycle time.

**Protect data and preserve evidence.** Minimise and redact data; use approved enterprise hosting, encryption, role-based access and retention limits; prohibit public-model use of claims data. Log claim inputs, retrieved sources, prompt/workflow, model and version, output, human edits, final rationale, overrides and timestamps.

**Govern suppliers and incidents.** Contract for confidentiality and data-use limits, audit/access rights, security, incident notification, subcontractor disclosure, model-change notice, continuity and exit. Require formal change control and regression testing for model, prompt, retrieval, tool, policy and vendor changes, with rapid rollback thresholds for leakage, material error, discriminatory patterns or claimant harm. Maintain manual processing, human correction/complaint and appeal routes. Board or senior management owns the outcomes, with independent validation/internal audit proportionate to risk.

EIOPA’s 2025 opinion similarly highlights data governance, record-keeping, fairness, cybersecurity, explainability and human oversight; New York DFS’s AI circular illustrates expectations for risk-based governance, quantitative adverse-effect testing, vendor oversight and accountability (although its scope is underwriting/pricing, not claims). Sources: [EIOPA](https://www.eiopa.europa.eu/eiopa-publishes-opinion-ai-governance-and-risk-management-2025-08-06_en); [NY DFS Circular Letter 7 (2024)](https://www.dfs.ny.gov/industry-guidance/circular-letters/cl2024-07).

## Practical 90-day starting point

1. Inventory and risk-tier every claims AI experiment; nominate a business owner and accountable claims executive.
2. Complete legal, privacy, security and vendor reviews; baseline current performance. Pilot one bounded internal workflow—file summarisation or policy retrieval—with source citations and no write-back to coverage, reserve, fraud, medical or payment decisions.
3. Establish a holdout test set containing rare, complex, multilingual and vulnerable-claim scenarios; define go/no-go thresholds for accuracy, omissions, bias, overrides and complaints, plus stop criteria.
4. Run in shadow mode, compare with normal handling, then release gradually with rollback and rapid incident review (not only a monthly review).
5. Expand only when measured customer and claims outcomes improve, not merely when handling time falls.

**Regulatory note:** requirements vary by jurisdiction and use case. In the EU, the AI Act expressly lists certain life/health risk-assessment and pricing systems as high-risk. Claims intake, summarisation, triage and fraud support are not automatically high-risk solely because they concern claims, but may be covered in other circumstances and remain subject to GDPR, insurance-sector, consumer-protection and discrimination rules. EIOPA stresses that existing insurance obligations already apply to AI. In the U.S., the NAIC Model Bulletin is a model—not automatically binding law—so state adoption and existing unfair-claims, privacy and discrimination rules matter. Treat IAIS/EIOPA/DFS materials as supervisory guidance or expectations, and label internal controls as policy choices rather than universal legal requirements. Where automated processing has legal or similarly significant effects, assess applicable data-protection safeguards (including GDPR Article 22 where relevant).
